BJ(BJ)
BJ
Q3 2026 EPS Estimate
$1.17
Aug 21, 2026 · Reports before open
Revenue Estimate
$5.97B
FY2027E EPS$4.52
FY2028E EPS$4.90
Analyst Sentiment
Wall St. Consensus
Hold25 analysts·High coverage
62
Score
13 Buy (52%)11 Hold (44%)1 Sell (4%)
Rating Breakdown
Strong Buy
00%
Buy
1352%
Hold
1144%
Sell
14%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$109.00
+16.4%
Consensus
$111.50
+19.0%
Bull
$114.00
+21.7%
12-Month Target Range25 analysts
$109.00$111.50$114.00
Current $93.67Consensus
Current Price
$93.67
Upside to Consensus
$17.83
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+10.39%
EPS+3.50%
FY2028
Rev+5.66%
EPS+8.34%
FY2029
Rev+5.66%
EPS+6.38%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $23.66B | $25.00B | $26.41B | $28.17B | $29.97B |
| Low | $22.34B | $24.09B | $25.52B | $26.84B | $28.55B |
| High | $25.01B | $26.55B | $28.01B | $29.88B | $31.78B |
| EBITDA Avg | $1.34B | $1.42B | $1.50B | $1.60B | $1.70B |
| Low | $1.27B | $1.37B | $1.45B | $1.52B | $1.62B |
| High | $1.42B | $1.51B | $1.59B | $1.69B | $1.80B |
| EBIT Avg | $933M | $986M | $1.04B | $1.11B | $1.18B |
| Low | $882M | $950M | $1.01B | $1.06B | $1.13B |
| High | $987M | $1.05B | $1.11B | $1.18B | $1.25B |
| Net Income Avg | $584M | $626M | $681M | $766M | $835M |
| Low | $582M | $619M | $656M | $719M | $783M |
| High | $606M | $673M | $718M | $826M | $900M |
| EPS Avg | $4.52 | $4.90 | $5.21 | $5.80 | $6.32 |
| Low | $4.41 | $4.69 | $4.97 | $5.44 | $5.93 |
| High | $4.59 | $5.10 | $5.44 | $6.26 | $6.82 |
| Analysts (Rev / EPS) | 17 / 16 | 16 / 15 | 9 / 5 | 4 / 1 | 3 / 2 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.89B | $6.11B | $6.03B | $6.30B | $6.30B | $6.61B | $6.26B | $6.26B |
| Low | $5.60B | $5.82B | $5.74B | $5.99B | $5.99B | $6.29B | $5.96B | $5.96B |
| High | $6.24B | $6.48B | $6.40B | $6.68B | $6.68B | $7.01B | $6.65B | $6.64B |
| EBITDA Avg | $334M | $347M | $342M | $357M | $357M | $374M | $355M | $355M |
| Low | $317M | $330M | $326M | $340M | $340M | $356M | $338M | $338M |
| High | $354M | $368M | $363M | $379M | $379M | $397M | $377M | $377M |
| EBIT Avg | $232M | $241M | $238M | $248M | $248M | $261M | $247M | $247M |
| Low | $221M | $230M | $227M | $236M | $236M | $248M | $235M | $235M |
| High | $246M | $256M | $253M | $264M | $264M | $276M | $262M | $262M |
| Net Income Avg | $160M | $132M | $159M | $160M | $172M | $144M | $149M | $172M |
| Low | $156M | $123M | $149M | $150M | $161M | $135M | $139M | $161M |
| High | $163M | $142M | $171M | $173M | $186M | $155M | $160M | $185M |
| EPS Avg | $1.23 | $1.02 | $1.23 | $1.24 | $1.33 | $1.11 | $1.15 | $1.33 |
| Low | $1.20 | $0.95 | $1.15 | $1.16 | $1.25 | $1.04 | $1.08 | $1.24 |
| High | $1.26 | $1.10 | $1.33 | $1.34 | $1.43 | $1.20 | $1.24 | $1.43 |
| Analysts (Rev / EPS) | 13 / 14 | 6 / 6 | 6 / 12 | 6 / 6 | 6 / 10 | 5 / 11 | 6 / 7 | 7 / 9 |